Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -21.6% | +57.7% | 2 / 3 | +6.0% | -3.44 pp | -3.87 pp | +10.1% | 0.31 | 10.26 | 42,5 | +6,0% | 4,7 | −21,6% | 10.26 | 17.28 | −40,6% |
| Pts | 0 | 12 | 8 | 0 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 11.900 (close price on 2026-09-15)EPS (TTM): 1.160
Financial charts
1.Revenue & growth
VND bn42,5Q2/26
1.Revenue & growth
VND bn42,5Q2/26
2.Profit & growth
VND bn4,67Q2/26
3.Profit mix (Penman)
VND bn22,6Q2/26
4.Margins & cost structure
%38.2%Q2/26
5.Returns & cash cycle
% · days8.3%Q2/26
6.Earnings quality & cash
VND bn24,8Q2/26
7.Asset structure
VND bn334Q2/26
8.Funding & debt health
VND bn · times334Q2/26
9.Revenue backlog
VND bn0,07Q2/26
10.Valuation
times · %10,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %301Q2/26
Adjusted EPS growth, latest quarter
-21.6%
Average adjusted EPS growth, 3 quarters
57.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26